Han Liu

Advancing anticancer dose selection and individualization

Liu, Han

2026

• Download full text (pdf) of Advancing anticancer dose selection and individualization

Integrated modeling of biomarkers, survival and safety in clinical oncology drug development

Liu, Han; Ibrahim, Eman I.K.; Centanni, Maddalena; Sarr, Céline et al.

Part of Advanced Drug Delivery Reviews, 2025

• DOI for Integrated modeling of biomarkers, survival and safety in clinical oncology drug development
• Download full text (pdf) of Integrated modeling of biomarkers, survival and safety in clinical oncology drug development

Multistate modeling for survival analysis in critically ill patients treated with meropenem

Peng, Yaru; Minichmayr, Iris; Liu, Han; Xie, Feifan et al.

Part of CPT, p. 222-233, 2024

• DOI for Multistate modeling for survival analysis in critically ill patients treated with meropenem
• Download full text (pdf) of Multistate modeling for survival analysis in critically ill patients treated with meropenem

A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non‐small cell lung cancer

Liu, Han; Milenković‐Grišić, Ana‐Marija; Krishnan, Sreenath M.; Jönsson, Siv et al.

Part of CPT, p. 1738-1750, 2023

• DOI for A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non‐small cell lung cancer
• Download full text (pdf) of A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non‐small cell lung cancer

A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancer.

Liu, Han; Milenković-Grišić, Ana-Marija; Madathil Krishnan, Sreenath; Jönsson, Siv et al.

Part of CPT, p. 1738-1750, 2023

• DOI for A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancer.

Integrated modeling of biomarkers, survival and safety in clinical oncology drug development

Liu, Han; Ibrahim, Eman I.K.; Centanni, Maddalena; Sarr, Céline et al.

Part of Advanced Drug Delivery Reviews, 2025

• DOI for Integrated modeling of biomarkers, survival and safety in clinical oncology drug development
• Download full text (pdf) of Integrated modeling of biomarkers, survival and safety in clinical oncology drug development

Multistate modeling for survival analysis in critically ill patients treated with meropenem

Peng, Yaru; Minichmayr, Iris; Liu, Han; Xie, Feifan et al.

Part of CPT, p. 222-233, 2024

• DOI for Multistate modeling for survival analysis in critically ill patients treated with meropenem
• Download full text (pdf) of Multistate modeling for survival analysis in critically ill patients treated with meropenem

A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non‐small cell lung cancer

Liu, Han; Milenković‐Grišić, Ana‐Marija; Krishnan, Sreenath M.; Jönsson, Siv et al.

Part of CPT, p. 1738-1750, 2023

• DOI for A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non‐small cell lung cancer
• Download full text (pdf) of A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non‐small cell lung cancer

A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancer.

Liu, Han; Milenković-Grišić, Ana-Marija; Madathil Krishnan, Sreenath; Jönsson, Siv et al.

Part of CPT, p. 1738-1750, 2023

• DOI for A multistate modeling and simulation framework to learn dose-response of oncology drugs: Application to bintrafusp alfa in non-small cell lung cancer.

Advancing anticancer dose selection and individualization

Liu, Han

2026

• Download full text (pdf) of Advancing anticancer dose selection and individualization

Time-related bias and confounding bias in toxicity-survival associations for antiCancer drugs

Liu, Han; Friberg, Lena E.

Bias in exposure-response analysis of sunitinib in renal cancer

Liu, Han; Friberg, Lena E.

Sex differences in sunitinib tolerability and patient-reported outcomes in metastatic renal cell carcinoma: the role of exposure and implications for precision dosing

Liu, Han; Friberg, Lena E.